508 related articles for article (PubMed ID: 21703676)
1. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.
Aujesky D; Roy PM; Verschuren F; Righini M; Osterwalder J; Egloff M; Renaud B; Verhamme P; Stone RA; Legall C; Sanchez O; Pugh NA; N'gako A; Cornuz J; Hugli O; Beer HJ; Perrier A; Fine MJ; Yealy DM
Lancet; 2011 Jul; 378(9785):41-8. PubMed ID: 21703676
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Büller HR; Gallus AS; Pillion G; Prins MH; Raskob GE;
Lancet; 2012 Jan; 379(9811):123-9. PubMed ID: 22130488
[TBL] [Abstract][Full Text] [Related]
3. Outpatient management of pulmonary embolism.
Howard L; Salooja N
Lancet; 2011 Jul; 378(9785):5-6. PubMed ID: 21703675
[No Abstract] [Full Text] [Related]
4. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
[TBL] [Abstract][Full Text] [Related]
5. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
6. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis.
Zondag W; Kooiman J; Klok FA; Dekkers OM; Huisman MV
Eur Respir J; 2013 Jul; 42(1):134-44. PubMed ID: 23100493
[TBL] [Abstract][Full Text] [Related]
7. Oral rivaroxaban for symptomatic venous thromboembolism.
; Bauersachs R; Berkowitz SD; Brenner B; Buller HR; Decousus H; Gallus AS; Lensing AW; Misselwitz F; Prins MH; Raskob GE; Segers A; Verhamme P; Wells P; Agnelli G; Bounameaux H; Cohen A; Davidson BL; Piovella F; Schellong S
N Engl J Med; 2010 Dec; 363(26):2499-510. PubMed ID: 21128814
[TBL] [Abstract][Full Text] [Related]
8. Day-patient treatment after short inpatient care versus continued inpatient treatment in adolescents with anorexia nervosa (ANDI): a multicentre, randomised, open-label, non-inferiority trial.
Herpertz-Dahlmann B; Schwarte R; Krei M; Egberts K; Warnke A; Wewetzer C; Pfeiffer E; Fleischhaker C; Scherag A; Holtkamp K; Hagenah U; Bühren K; Konrad K; Schmidt U; Schade-Brittinger C; Timmesfeld N; Dempfle A
Lancet; 2014 Apr; 383(9924):1222-9. PubMed ID: 24439238
[TBL] [Abstract][Full Text] [Related]
9. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
Beyer-Westendorf J; Schellong SM; Gerlach H; Rabe E; Weitz JI; Jersemann K; Sahin K; Bauersachs R;
Lancet Haematol; 2017 Mar; 4(3):e105-e113. PubMed ID: 28219692
[TBL] [Abstract][Full Text] [Related]
10. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Hornick P;
Lancet; 2010 Mar; 375(9717):807-15. PubMed ID: 20206776
[TBL] [Abstract][Full Text] [Related]
11. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.
Wells PS; Kovacs MJ; Bormanis J; Forgie MA; Goudie D; Morrow B; Kovacs J
Arch Intern Med; 1998 Sep; 158(16):1809-12. PubMed ID: 9738611
[TBL] [Abstract][Full Text] [Related]
12. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
13. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Rosencher N; Kurth AA; van Dijk CN; Frostick SP; Prins MH; Hettiarachchi R; Hantel S; Schnee J; Büller HR;
Lancet; 2007 Sep; 370(9591):949-56. PubMed ID: 17869635
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with enoxaparin for the prevention of recurrent venous thromboembolism.
Castro DJ; Díaz G; Martí D; Escobar C; Ortega J; García-Rull S; Picher J; Sueiro A
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):173-7. PubMed ID: 17287635
[TBL] [Abstract][Full Text] [Related]
15. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
[TBL] [Abstract][Full Text] [Related]
16. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
[TBL] [Abstract][Full Text] [Related]
17. Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study.
Hacobian M; Shetty R; Niles CM; Gerhard-Herman M; Vallurupalli N; Baroletti S; McKean SC; Sonis J; Parasuraman S; Kosowsky JM; Goldhaber SZ
Clin Appl Thromb Hemost; 2010 Feb; 16(1):21-5. PubMed ID: 19147527
[TBL] [Abstract][Full Text] [Related]
18. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
Cools F; Virdone S; Sawhney J; Lopes RD; Jacobson B; Arcelus JI; Hobbs FDR; Gibbs H; Himmelreich JCL; MacCallum P; Schellong S; Haas S; Turpie AGG; Ageno W; Rocha AT; Kayani G; Pieper K; Kakkar AK;
Lancet Haematol; 2022 Aug; 9(8):e594-e604. PubMed ID: 35779560
[TBL] [Abstract][Full Text] [Related]
19. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
Amin AN; Lin J; Thompson S; Wiederkehr D
Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
[TBL] [Abstract][Full Text] [Related]
20. Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization: The Low-Risk Pulmonary Embolism Prospective Management Study.
Bledsoe JR; Woller SC; Stevens SM; Aston V; Patten R; Allen T; Horne BD; Dong L; Lloyd J; Snow G; Madsen T; Elliott CG
Chest; 2018 Aug; 154(2):249-256. PubMed ID: 29410163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
